Mi Qi
Impact in
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Influenza Virus Research Studies 3
- Respiratory viral infections research 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Xiaowei Zhang (6 shared papers)Zongqiang Cui (6 shared papers)Xian‐En Zhang (6 shared papers)Zhiping Zhang (4 shared papers)Wei Li (1 shared paper)Jianjun Chen (3 shared papers)Siling Liu (2 shared papers)Ze Chen (2 shared papers)
- Journals
- Small (2 papers)International Journal of Nanomedicine (1 paper)ACS Nano (1 paper)Molecular Therapy (1 paper)Nanoscale (1 paper)
- Partner nations
- China
In The Last Decade
Mi Qi
8 papers receiving 338 citations
Peers
Comparison fields: 5 of 70
- Immunology 120
- Infectious Diseases 78
- Biomaterials 46
- Animal Science and Zoology 28
- Epidemiology 81
Countries citing papers authored by Mi Qi
This map shows the geographic impact of Mi Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Qi more than expected).
Fields of papers citing papers by Mi Qi
This network shows the impact of papers produced by Mi Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Qi. The network helps show where Mi Qi may publish in the future.
Co-authors
The 21 scholars most cited alongside Mi Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 97 | |
| 2 | 2018 | 83 | |
| 3 | 2020 | 73 | |
| 4 | 2023 | 42 | |
| 5 | 2020 | 19 | |
| 6 | 2022 | 16 | |
| 7 | 2024 | 11 | |
| 8 | 2018 | 3 |
About Mi Qi
Mi Qi is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Genetics, having authored 8 papers that have together received 344 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (3 papers), Respiratory viral infections research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), interferon and immune responses (1 paper), Trace Elements in Health (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Immunology (120 citations), Infectious Diseases (78 citations), Biomaterials (46 citations), Animal Science and Zoology (28 citations) and Epidemiology (81 citations). Mi Qi has collaborated with scholars based in China. Frequent co-authors include Xiaowei Zhang, Zongqiang Cui, Xian‐En Zhang, Zhiping Zhang, Wei Li, Jianjun Chen, Wei Li, Siling Liu, Ze Chen and Yanfeng Yao. Their work appears in journals such as Small, International Journal of Nanomedicine, ACS Nano, Molecular Therapy and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.